Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 4234 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 11 12 13 ... 41 42 43  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Midatech Pharma plc. (10/11/16). "Press Release: Results of Placing to raise £16.0 million and PDMR Shareholding [Not for United States, Canada, Australia, South Africa, Japan, New Zealand, et al.]". 2016-10-11
Kymab Ltd.. (10/11/16). "Press Release: Bispecific Antibody Agreement with EpimAb". 2016-10-11
Arcis Biotechnology Ltd.. (10/11/16). "Press Release: Arcis Biotechnology Launches IVD for the Preparation of DNA from Blood". Daresbury. 2016-10-11
bioMérieux S.A.. (10/10/16). "Press Release: BIOASTER, bioMérieux, ESPCI, GSK, Hospices Civils de Lyon and Sanofi Join Forces against Sepsis". 2016-10-10
Molecular Partners AG. (10/10/16). "Press Release: Molecular Partners’ Strategic Partner Allergan to Present Abicipar Phase 2 Data of PALM Study in Diabetic Macular Edema (DME) at the 2016 AAO Annual Meeting". Zürich-Schlieren. 2016-10-10
Crescendo Biologics Ltd.. (10/10/16). "Press Release: Crescendo Biologics and Takeda Enter Collaboration for Humabody-based Therapeutics Worth up to $790m". Cambridge & Osaka. 2016-10-10
Helsinn Healthcare S.A.. (10/10/16). "Press Release: Helsinn Group Creates New Investment Fund in 40th Anniversary Year". Lugano. 2016-10-10
Molecular Partners AG. (10/9/16). "Press Release: Molecular Partners Presents Data of MP0250 in an All-comer Phase 1-Study in Solid Tumor Patients and Updates on Phase 2 Studies". Zürich-Schlieren. 2016-10-09
Malin Corporation plc. (10/7/16). "Press Release: Malin Corporation plc Appoints Peter Schwartzman to Senior Management Team". Dublin. 2016-10-07
Thermosome GmbH. (10/6/16). "Press Release: Thermosome Appoints Dr. Ulrich Grau, Dr. Jochen Knolle and Dr. Franz-Robert Klingan to Its Advisory Board". Martinsried. 2016-10-06
Bluebee. (10/6/16). "Press Release: Bluebee Achieves ISO/IEC 27001:2013 Accreditation". 2016-10-06
Orchard Therapeutics Ltd.. (10/6/16). "Press Release: Orchard Therapeutics Announces the Opening of US Operations in Foster City, California". London. 2016-10-06
Syncona LLP. (10/5/16). "Press Release: Achilles Therapeutics Launched with Funds of £13.2 Million to Develop Immunotherapies for Cancer". 2016-10-05
Evotec AG. (10/4/16). "Press Release: Evotec and Carrick Therapeutics Build Strategic Alliance". Hamburg. 2016-10-04
Owlstone Medical. (10/4/16). "Press Release: Owlstone Medical Receives CE Mark Approval for Pediatric Disease Breathalyzer". Cambridge. 2016-10-04
Curetis N.V.. (10/4/16). "Press Release: Curetis to Present at Several Investor and Scientific Conferences in the Fourth Quarter 2016". Amsterdam & Holzgerlingen. 2016-10-04
Healx Ltd.. (10/4/16). "Press Release: Healx Announces £1.5m Investment Led by Jonathan Milner". 2016-10-04
Carrick Therapeutics Ltd.. (10/3/16). "Press Release: Launch of Carrick Therapeutics Signals New Approach to Cancer Therapies. $95m Initial Funding from Leading Investor Syndicate". Dublin. 2016-10-03
ReViral Ltd.. (10/3/16). "Press Release: ReViral Announces Appointment of New Chief Executive Officer". London. 2016-10-03
Prothena Corporation plc. (10/3/16). "Press Release: Prothena Announces Appointment of Dr. Gene G. Kinney as President, Chief Executive Officer and Director". Dublin. 2016-10-03
AstraZeneca plc. (9/30/16). "Press Release: AstraZeneca Presents New Data on Faslodex in Breast Cancer and Provides Immuno-oncology Update at ESMO 2016 Congress". 2016-09-30
Sanofi S.A.. (9/30/16). "Press Release: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare". Paris. 2016-09-30
DNA Electronics Ltd.. (9/30/16). "Press Release: BARDA Awards $51.9 Million Contract to DNAe to Develop Semiconductor DNA Sequencing Platform for Rapid Diagnosis of Antimicrobial Resistant Infections and Influenza". London & Carlsbad, CA. 2016-09-30
Qiagen N.V.. (9/29/16). "Press Release: Qiagen and ICMP to Develop First NGS Workflow for Identification of Missing Persons". Hilden & The Hague. 2016-09-29
GlaxoSmithKline plc. (9/29/16). "Press Release: GlaxoSmithKline plc Appoints Brian McNamara as CEO of GSK Consumer Healthcare". London. 2016-09-29
AB Science S.A.. (9/29/16). "Press Release: Filing of Masitinib in the Treatment of Amyotrophic Lateral Sclerosis (ALS) to the European Medicines Agency (EMA)". Paris. 2016-09-29
Atlantic Healthcare plc. (9/29/16). "Press Release: Atlantic Healthcare Appoints Karl Keegan as Chief Financial Officer". Cambridge & Raleigh, NC. 2016-09-29
AstraZeneca plc. (9/28/16). "Press Release: AstraZeneca Appoints David Goldstein as Chief Adviser for Its Genomics Initiative". 2016-09-28
GlaxoSmithKline plc. (9/28/16). "Press Release: GlaxoSmithKline Announces Intention to Sell Remaining Holding in Aspen". London. 2016-09-28
GlaxoSmithKline plc. (9/28/16). "Press Release: GlaxoSmithKline Completes Sale of Remaining Aspen Shares". London. 2016-09-28
Evotec AG. (9/28/16). "Press Release: Evotec Enters into Strategic Multi-target Alliance with C4X Discovery". Hamburg. 2016-09-28
Oncodesign S.A.. (9/28/16). "Press Release: GSK and Oncodesign Announce Agreement for Oncodesign’s Acquisition of GSK’s Research Centre in France". 2016-09-28
Microsaic Systems plc. (9/28/16). "Press Release: Retirement of Chairman". 2016-09-28
Medigene AG. (9/26/16). "Press Release: Medigene Participates at Five National and International Conferences". Martinsried. 2016-09-26
Adaptimmune Therapeutics plc. (9/26/16). "Press Release: MD Anderson Cancer Center and Adaptimmune Form Strategic Alliance to Advance Development of Immunotherapies Targeting Multiple Cancers". Philadeliphia, PA, Houston, TX & Oxford. 2016-09-26
Cyprotex plc. (9/26/16). "Press Release: Cyprotex Appoint New Director of US Operations". 2016-09-26
Genomics England Ltd.. (9/23/16). "Press Release: GenomOncology’s Knowledge Management System to Analyse Cancer Samples in the 100,0000 Genomes Project". 2016-09-23
Saneca Pharma. (9/22/16). "Press Release: Saneca Pharma Strengthens Senior Team". 2016-09-22
Ergomed plc. (9/22/16). "Press Release: Ergomed’s Full Service Contract Win Validates Strategic Rationale of Recent Acquisitions". London. 2016-09-22
Owlstone Medical. (9/22/16). "Press Release: Owlstone Medical Commences Next Phase in World’s Largest Breath-based Clinical Trial for Early Cancer Detection". Cambridge. 2016-09-22
Sygnis AG. (9/22/16). "Press Release: Sygnis AG Enters into Collaboration Agreement with ECACC for Licensing and Distribution of Caco-2 Cell Line". Madrid & Heidelberg. 2016-09-22
Gyros Protein Technologies AB. (9/22/16). "Press Release: Gyros Protein Technologies Establishes Dedicated Office in Japan". Uppsala. 2016-09-22
PharmaMar S.A.. (9/22/16). "Press Release: PharmaMar Submits MAA to EMA for Aplidin for the Treatment of Multiple Myeloma". Madrid. 2016-09-22
Proteome Sciences plc. (9/22/16). "Press Release: Study Demonstrates Mass Spectrometry Technique Dramatically Enhances Detection of Key Early Stage Alzheimer's Biomarkers. Publication: Journal of Alzheimer's disease". Cobham. 2016-09-22
4SC AG. (9/21/16). "Press Release: Dr Jason Loveridge Appointed New CEO of 4SC". Planegg-Martinsried. 2016-09-21
Artios Pharma Ltd.. (9/21/16). "Press Release: Artios Pharma Company Launch and Fundraising of $33.2 Million to Focus on Novel DNA Damage Response (DDR) Cancer Therapies". Cambridge. 2016-09-21
Imperial Innovations Group plc. (9/21/16). "Press Release: Innovations Invests £5.1m in Artios Pharma Limited". 2016-09-21
Orchard Therapeutics Ltd.. (9/21/16). "Press Release: Orchard Therapeutics Announces Presentations from UCL/GOSH and UCLA Academic Collaborators on Clinical Data in ADA-SCID Using Ex-Vivo Lentiviral Gene Therapy at September 2016 ESID and ESGCT Congresse 2016-09-21
GlaxoSmithKline plc. (9/20/16). "Press Release: Emma Walmsley to Succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline". London. 2016-09-20
Adaptimmune Therapeutics plc. (9/19/16). "Press Release: Adaptimmune Announces Strategic Manufacturing Agreement with PCT to Support Development of SPEAR T-cell Therapies Towards Commercialization". Philadeliphia, PA & Oxford. 2016-09-19
Enterome Bioscience S.A.. (9/19/16). "Press Release: Enterome Appoints Christophe Bonny as Chief Scientific Officer". Paris & Cambridge, MA. 2016-09-19
Sanofi S.A.. (9/16/16). "Press Release: Treatment Effects Maintained Over Six Years in Patients with Relapsing Remitting Multiple Sclerosis who Received Sanofi Genzyme’s Lemtrada (alemtuzumab) in Clinical Trials". Paris. 2016-09-16
Abingworth LLP. (9/16/16). "Press Release: GammaDelta Therapeutics Raises Seed Funding from Abingworth". 2016-09-16
Boehringer Ingelheim. (9/16/16). "Press Release: Glyxambi (empagliflozin/linagliptin) Approval Recommended by CHMP for Adults with Type 2 Diabetes in the European Union". Ingelheim & Indianapolis, IN. 2016-09-16
Merck KGaA. (9/16/16). "Press Release: Merck Presents New Data Examining Durable Efficacy with Investigational Cladribine Tablets in Multiple Sclerosis". Darmstadt. 2016-09-16
PsiOxus Therapeutics Ltd.. (9/16/16). "Press Release: PsiOxus Therapeutics Announce Executive Team Reorganization with Two New C Level Appointments in the US". Oxford. 2016-09-16
Proteome Sciences plc. (9/15/16). "Press Release: Interim Results. Proteome Sciences Today Releases Its Unaudited Interim Results for the Six Months Ended 30th June 2016". 2016-09-15
Loughborough University. (9/15/16). "Press Release: Loughborough Researchers Develop Simple Saliva Test to Diagnose Asthma". 2016-09-15
Merck KGaA. (9/14/16). "Press Release: Merck Joins DiViNe Consortium to Address Low Yields, High Costs of Vaccine Purification Processes". Darmstadt. 2016-09-14
Merck KGaA. (9/12/16). "Press Release: Merck Presents New Data on the Safety and Durable Efficacy of Cladribine Tablets and Advantages of Early Treatment with Rebif at the 2016 ECTRIMS Congress". Darmstadt. 2016-09-12
MorphoSys AG. (9/12/16). "Press Release: MorphoSys Appoints Four R&D Experts to Its Newly Formed Scientific Advisory Board". 2016-09-12
Janssen-Cilag International N.V.. (9/12/16). "Press Release: Janssen Submits Application Seeking Approval of Sirukumab in European Union for Rheumatoid Arthritis". Beerse. 2016-09-12
Janssen-Cilag International N.V.. (9/12/16). "Press Release: Janssen Submits Marketing Authorisation Application for Darunavir-based Single Tablet Regimen for Treatment of HIV-1 to European Medicines Agency". Beerse. 2016-09-12
Kymab Ltd.. (9/9/16). "Press Release: Kymab's Early Steps Towards HIV Vaccine". Cambridge. 2016-09-09
Vivasure Medical Ltd.. (9/8/16). "Press Release: Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States". Galway. 2016-09-08
Cellectricon AB. (9/8/16). "Press Release: Cellectricon and Censo Biotechnologies Collaborate to Offer High-quality Human iPSC-based Discovery Services for CNS and Pain Research". Mölndal & Cambridge. 2016-09-08
Innate Pharma S.A.. (9/8/16). "Press Release: First Half of 2016 – Building Momentum through Clinical Development and New Partnerships". 2016-09-08
Adaptimmune Therapeutics plc. (9/8/16). "Press Release: Adaptimmune to Participate in Two Upcoming Investor Conferences". Philadeliphia, PA & Oxford. 2016-09-08
Evonik Industries AG. (9/7/16). "Press Release: Venture Capital. Evonik Invests in Irish Medical Device Company Vivasure Medical". Essen. 2016-09-07
Horizon Discovery Group plc. (9/6/16). "Press Release: Horizon Discovery and Fulcrum Therapeutics Form Collaboration for Novel CRISPR-Based Target Discovery in Genetic Diseases". Cambridge. 2016-09-06
RHAPSODY Project (IMI). (9/5/16). "Press Release: Launch of RHAPSODY. An Innovative Medicines Initiative Project for Precision Therapy and Prevention of Diabetes". Frankfurt, Lausanne, Suresnes & Lund. 2016-09-05
Peak Scientific Instruments Ltd.. (9/1/16). "Press Release: Peak Introduces Solaris Nitrogen – Gas Solution for ELSD & Compact MS Applications". 2016-09-01
MRC Technology. (9/1/16). "Press Release: New Collaboration to Explore Novel Treatments for Respiratory Diseases". London. 2016-09-01
Oryzon Genomics S.A.. (9/1/16). "Press Release: Oryzon Genomics to Present at the 18th Annual Rodman & Renshaw Global Investment Conference and at BioPharm America 2016". Barcelona & Cambridge, MA. 2016-09-01
Oxford Immunotec Global plc. (9/1/16). "Press Release: Oxford Immunotec Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation". Oxford & Marlborough, MA. 2016-09-01
CiToxLab. (9/1/16). "Press Release: CiToxLab Appoints Alan Bartlett as Senior Director, Global Laboratory Operations". Evreux & Montréal. 2016-09-01
Horizon Discovery Group plc. (9/1/16). "Press Release: Horizon Discovery Group and Ventana Medical Systems Sign Co-development Agreement for Reference Standards". Cambridge. 2016-09-01
Phagenesis Ltd.. (9/1/16). "Press Release: The Staged Acquisition of Phagenesis by Nestlé Health Science Will Benefit Patients with Dysphagia". Manchester. 2016-09-01
Roche. (9/1/16). "Press Release: Phase III Efficacy Results of Investigational Medicine Ocrevus (ocrelizumab) Reinforced by Exploratory Analyses in Two Forms of Multiple Sclerosis". Basel. 2016-09-01
Novasep S.A.. (9/1/16). "Press Release: Demonstration Project Started for the Conversion of Woody Biomass to Chemicals". Brussels. 2016-09-01
Neovacs S.A.. (8/30/16). "Press Release: Neovacs to Present at Two Major Investor Conferences. The 18th Annual Rodman & Renshaw Global Investment Conference & Bio Europe 2016". Paris & Boston, MA. 2016-08-30
Definiens AG. (8/30/16). "Press Release: Definiens Expands Boston-based Office in Response to Growth in U.S. Market. Cambridge, MA to Become New U.S. Headquarters". Munich. 2016-08-30
MorphoSys AG. (8/29/16). "Press Release: MorphoSys to Present at Upcoming Investor Conferences". 2016-08-29
Boehringer Ingelheim. (8/29/16). "Press Release: Latest Data on Dabigatran Etexilate Safety and Effectiveness Profile Show Low Rates of Bleeding and Stroke in NVAF Patients in Routine Clinical Care". Ingelheim. 2016-08-29
Microsaic Systems plc. (8/26/16). "Press Release: Interim Results and Management Update for the Six Months Ended 30 June 2016". 2016-08-26
Microsaic Systems plc. (8/26/16). "Press Release: Result of Placing". 2016-08-26
Microsaic Systems plc. (8/26/16). "Press Release: Proposed Placing of up to 108,000,000 New Ordinary Shares at 5 Pence per Share and Notice of General Meeting". 2016-08-26
SpectralWorks Ltd.. (8/26/16). "Press Release: SpectralWorks Releases AnalyzerPro Version 5.3". 2016-08-26
Denali Therapeutics Inc.. (8/25/16). "Press Release: Denali Therapeutics Announces First Clinical Trial Application, Key Collaborations and $130m Series B". South San Francisco, CA. 2016-08-25
F-Star Biotechnology Ltd.. (8/25/16). "Press Release: F-Star Announces Collaborative Agreement with Denali Therapeutics for the Development of a Multispecific Antibody Platform to Deliver Therapeutics across the Blood-Brain Barrier". Cambridge & South Sa 2016-08-25
Owlstone Medical. (8/25/16). "Press Release: Owlstone Medical Strengthens Management Team. Chris Hodkinson, Dr Marc van der Schee and Hamilton Scanlon Join the Company". Cambridge. 2016-08-25
Cyprotex plc. (8/25/16). "Press Release: Cyprotex Install Two AB Sciex TripleTOF 6600 Mass Spectrometer Systems". 2016-08-25
AstraZeneca plc. (8/24/16). "Press Release: AstraZeneca to Sell Small Molecule Antibiotics Business to Pfizer. Value-creating Divestment Supports AstraZeneca’s Focus on Three Main Therapy Areas". 2016-08-24
Oxford Immunotec Global plc. (8/24/16). "Press Release: Oxford Immunotec to Present at the Baird 2016 Global Healthcare Conference". Oxford & Marlborough, MA. 2016-08-24
GE Healthcare. (8/23/16). "Press Release: GE Healthcare Expands Cell Therapy Portfolio with License of Stemcell Technologies’ T-Cell Reagents". Chalfont St. Giles. 2016-08-23
Waters Corporation. (8/23/16). "Press Release: Waters and NIBRT Researchers Generate Reference Library for Released N-Glycans Labeled with RapiFluor-MS". Toronto, ON. 2016-08-23
AstraZeneca plc. (8/22/16). "Press Release: AstraZeneca and Lilly Receive FDA Fast Track Designation for AZD3293, an Investigational Treatment for Early Alzheimer’s Disease". 2016-08-22
Consilium Strategic Communications Ltd.. (8/22/16). "Press Release: Consilium Strategic Communications Advises Cambridge Innovation Capital on Its £75m Fundraise". 2016-08-22
Bayer AG. (8/19/16). "Press Release: Bayer and CRISPR Therapeutics Joint Venture, Named Casebia Therapeutics, Establishes Operations in Cambridge, MA". Leverkusen & Basel. 2016-08-19
Cambridge Innovation Capital plc. (8/19/16). "Press Release: Cambridge Innovation Capital Raises £75 Million via Private Financing". 2016-08-19
next pagenext page 1 2 3 ... 11 12 13 ... 41 42 43  next pagenext page



Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

» top